Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets

被引：246

作者：

Taylor, Olivia G. ^{[1
,2
,3
]}

Brzozowski, Joshua S. ^{[1
,2
,3
]}

Skelding, Kathryn A. ^{[1
,2
,3
]}

机构：

[1] Univ Newcastle, Prior Res Ctr Canc Res Innovat & Translat, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW, Australia

[2] Hunter Med Res Inst, Hunter Canc Res Alliance, New Lambton Hts, NSW, Australia

[3] Hunter Med Res Inst, Canc Res Program, New Lambton Hts, NSW, Australia

来源：

FRONTIERS IN ONCOLOGY | 2019年 / 9卷

关键词：

glioblastoma; targeted therapeutics; anti-cancer drugs; brain cancer; immunotherapy; ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; PHASE-II TRIAL; C-MET; PROGNOSTIC-SIGNIFICANCE; TUMOR-GROWTH; RADIATION-THERAPY; MALIGNANT GLIOMAS; TEMOZOLOMIDE; EXPRESSION;

D O I：

10.3389/fonc.2019.00963

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumour in humans and has a very poor prognosis. The existing treatments have had limited success in increasing overall survival. Thus, identifying and understanding the key molecule(s) responsible for the malignant phenotype of GBM will yield new potential therapeutic targets. The treatment of brain tumours faces unique challenges, including the presence of the blood brain barrier (BBB), which limits the concentration of drugs that can reach the site of the tumour. Nevertheless, several promising treatments have been shown to cross the BBB and have shown promising pre-clinical results. This review will outline the status of several of these promising targeted therapies.

引用

页数：11

共 110 条

[1] Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis [J].

Abounader, R ;

Laterra, J .

NEURO-ONCOLOGY, 2005, 7 (04) :436-451

[2] Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies [J].

An, Zhenyi ;

Aksoy, Ozlem ;

Zheng, Tina ;

Fan, Qi-Wen ;

Weiss, William A. .

ONCOGENE, 2018, 37 (12) :1561-1575

[3] Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].

Bao, Shideng ;

Wu, Qiulian ;

McLendon, Roger E. ;

Hao, Yueling ;

Shi, Qing ;

Hjelmeland, Anita B. ;

Dewhirst, Mark W. ;

Bigner, Darell D. ;

Rich, Jeremy N. .

NATURE, 2006, 444 (7120) :756-760

[4] PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3 [J].

Benitez, Jorge A. ;

Ma, Jianhui ;

D'Antonio, Matteo ;

Boyer, Antonia ;

Camargo, Maria Fernanda ;

Zanca, Ciro ;

Kelly, Stephen ;

Khodadadi-Jamayran, Alireza ;

Jameson, Nathan M. ;

Andersen, Michael ;

Miletic, Hrvoje ;

Saberi, Shahram ;

Frazer, Kelly A. ;

Cavenee, Webster K. ;

Furnari, Frank B. .

NATURE COMMUNICATIONS, 2017, 8

[5]

Branter Joshua, 2018, Oncotarget, V9, P36631, DOI 10.18632/oncotarget.26344

[6] The Somatic Genomic Landscape of Glioblastoma [J].

Brennan, Cameron W. ;

Verhaak, Roel G. W. ;

McKenna, Aaron ;

Campos, Benito ;

Noushmehr, Houtan ;

Salama, Sofie R. ;

Zheng, Siyuan ;

Chakravarty, Debyani ;

Sanborn, J. Zachary ;

Berman, Samuel H. ;

Beroukhim, Rameen ;

Bernard, Brady ;

Wu, Chang-Jiun ;

Genovese, Giannicola ;

Shmulevich, Ilya ;

Barnholtz-Sloan, Jill ;

Zou, Lihua ;

Vegesna, Rahulsimham ;

Shukla, Sachet A. ;

Ciriello, Giovanni ;

Yung, W. K. ;

Zhang, Wei ;

Sougnez, Carrie ;

Mikkelsen, Tom ;

Aldape, Kenneth ;

Bigner, Darell D. ;

Van Meir, Erwin G. ;

Prados, Michael ;

Sloan, Andrew ;

Black, Keith L. ;

Eschbacher, Jennifer ;

Finocchiaro, Gaetano ;

Friedman, William ;

Andrews, David W. ;

Guha, Abhijit ;

Iacocca, Mary ;

O'Neill, Brian P. ;

Foltz, Greg ;

Myers, Jerome ;

Weisenberger, Daniel J. ;

Penny, Robert ;

Kucherlapati, Raju ;

Perou, Charles M. ;

Hayes, D. Neil ;

Gibbs, Richard ;

Marra, Marco ;

Mills, Gordon B. ;

Lander, Eric ;

Spellman, Paul ;

Wilson, Richard .

CELL, 2013, 155 (02) :462-477

[7] Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer [J].

Burger, Matthew T. ;

Pecchi, Sabina ;

Wagman, Allan ;

Ni, Zhi-Jie ;

Knapp, Mark ;

Hendrickson, Thomas ;

Atallah, Gordana ;

Pfister, Keith ;

Zhang, Yanchen ;

Bartulis, Sarah ;

Frazier, Kelly ;

Ng, Simon ;

Smith, Aaron ;

Verhagen, Joelle ;

Haznedar, Joshua ;

Huh, Kay ;

Iwanowicz, Ed ;

Xin, Xiaohua ;

Menezes, Daniel ;

Merritt, Hanne ;

Lee, Isabelle ;

Wiesmann, Marion ;

Kaufman, Susan ;

Crawford, Kenneth ;

Chin, Michael ;

Bussiere, Dirksen ;

Shoemaker, Kevin ;

Zaror, Isabel ;

Maira, Sauveur-Michel ;

Voliva, Charles F. .

ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (10) :774-779

[8] PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database [J].

Cantanhede, Isabella Gomes ;

Mendes de Oliveira, Joao Ricardo .

SCIENTIFIC REPORTS, 2017, 7

[9] RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients [J].

Chakravarti, Arnab ;

Wang, Meihua ;

Robins, H. Ian ;

Lautenschlaeger, Tim ;

Curran, Walter J. ;

Brachman, David G. ;

Schultz, Christopher J. ;

Choucair, Ali ;

Dolled-Filhart, Marisa ;

Christiansen, Jason ;

Gustavson, Mark ;

Molinaro, Annette ;

Mischel, Paul ;

Dicker, Adam P. ;

Bredel, Markus ;

Mehta, Minesh .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05) :1206-1211

[10] EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines [J].

Chakravarty, Debyani ;

Pedraza, Alicia M. ;

Cotari, Jesse ;

Liu, Angela H. ;

Punko, Diana ;

Kokroo, Aushim ;

Huse, Jason T. ;

Altan-Bonnet, Gregoire ;

Brennan, Cameron W. .

SCIENTIFIC REPORTS, 2017, 7

← 1 2 3 4 5 6 7 8 9 10 →